Catalyst Wire Dossier Catalyst Wire Dossier

AGN-190584

· AbbVie
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for AGN-190584, covering 2015-12-03 to 2024-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of Age [Phase 3]

See pricing